XML 30 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
9 Months Ended
Oct. 02, 2020
Stockholders Equity Note [Abstract]  
Stockholders' Equity

Note 11 — Stockholders’ Equity

Stock-Based Compensation

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 2, 2020

 

 

September 27, 2019

 

 

October 2, 2020

 

 

September 27, 2019

 

Employee stock options

 

$

2,469

 

 

$

2,178

 

 

$

7,206

 

 

$

5,770

 

Restricted stock

 

 

119

 

 

 

77

 

 

 

273

 

 

 

236

 

Restricted stock units

 

 

415

 

 

 

246

 

 

 

1,238

 

 

 

1,661

 

Performance stock units

 

 

54

 

 

 

 

 

 

54

 

 

 

 

Nonemployee stock options

 

 

69

 

 

 

57

 

 

 

194

 

 

 

111

 

Total stock-based compensation expense

 

$

3,126

 

 

$

2,558

 

 

$

8,965

 

 

$

7,778

 

 

The Company recorded stock-based compensation costs in the following categories (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 2, 2020

 

 

September 27, 2019

 

 

October 2, 2020

 

 

September 27, 2019

 

Cost of sales

 

$

30

 

 

$

7

 

 

$

82

 

 

$

43

 

General and administrative

 

 

1,307

 

 

 

1,082

 

 

 

3,601

 

 

 

2,878

 

Marketing and selling

 

 

807

 

 

 

692

 

 

 

2,674

 

 

 

2,553

 

Research and development

 

 

982

 

 

 

777

 

 

 

2,608

 

 

 

2,304

 

Total stock-based compensation expense, net

 

 

3,126

 

 

 

2,558

 

 

 

8,965

 

 

 

7,778

 

Amounts capitalized as part of inventory

 

 

287

 

 

 

258

 

 

 

847

 

 

 

723

 

Total stock-based compensation expense, gross

 

$

3,413

 

 

$

2,816

 

 

$

9,812

 

 

$

8,501

 

 

Incentive Plan

The Amended and Restated Omnibus Equity Incentive Plan (“the Plan”) provides for various forms of stock-based incentives. To date, of the available forms of awards under the Plan, the Company has granted only stock options, restricted stock, unrestricted share grants, restricted stock units (“RSUs”) and performance stock units (“PSUs”). Options under the Plan are granted at fair market value on the date of grant, become exercisable generally over a three-year period, or as determined by the Board of Directors, and expire over periods not exceeding 10 years from the date of grant. Certain option and share awards provide for accelerated vesting if there is a change in control and pre-established financial metrics are met (as defined in the Plan). Grants of restricted stock outstanding under the Plan generally vest over periods of one to three years. Grants of RSUs and PSUs outstanding under the Plan generally vest based on service, performance, or a combination of both.  On July 30, 2020, stockholders approved a proposal to increase the number of shares under the plan by 2,650,000 shares, for a total of 18,035,000 shares. As of October 2, 2020, there were 3,376,152 shares available for grant under the Plan.

Assumptions

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model applying the weighted-average assumptions noted in the following table.  Expected volatilities are based on historical volatility of the Company’s stock. The expected term of options granted is derived from the historical exercises and post-vesting cancellations and represents the period of time that options granted are expected to be outstanding.  The Company has calculated an 6% estimated forfeiture rate based on historical forfeiture experience.  The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.  

Note 11 — Stockholders’ Equity (Continued)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 2, 2020

 

 

September 27, 2019

 

 

October 2, 2020

 

 

September 27, 2019

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

53

%

 

 

53

%

 

 

53

%

 

 

53

%

Risk-free interest rate

 

 

0.31

%

 

 

1.55

%

 

 

0.53

%

 

 

2.40

%

Expected term (in years)

 

 

5.72

 

 

 

5.67

 

 

 

5.72

 

 

 

5.67

 

 

Stock Options

A summary of stock option activity under the Plan for the nine months ended October 2, 2020 is presented below:

 

 

 

Stock

Options

(in 000’s)

 

 

Minimum

Exercise

Price

 

 

Maximum

Exercise

Price

 

Outstanding at January 3, 2020

 

 

4,326

 

 

 

 

 

 

 

 

 

Granted

 

 

616

 

 

 

 

 

 

 

 

 

Exercised

 

 

(1,146

)

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(14

)

 

 

 

 

 

 

 

 

Outstanding at October 2, 2020

 

 

3,782

 

 

$

5.05

 

 

$

51.42

 

Exercisable at October 2, 2020

 

 

2,594

 

 

 

 

 

 

 

 

 

 

Restricted Stock, Restricted Stock Units and Performance Stock Units

A summary of restricted stock, RSUs and PSUs activity under the Plan for the nine months ended October 2, 2020 is presented below:

 

 

 

Restricted

Stock

(in 000’s)

 

 

Restricted

Stock

Units

(in 000’s)

 

 

Performance

Stock

Units

(in 000’s)

 

Unvested at January 3, 2020

 

 

11

 

 

 

104

 

 

 

 

Granted

 

 

11

 

 

 

127

 

 

 

15

 

Vested

 

 

(11

)

 

 

(93

)

 

 

 

Forfeited or expired

 

 

 

 

 

(1

)

 

 

 

Unvested at October 2, 2020

 

 

11

 

 

 

137

 

 

 

15